» Articles » PMID: 38271353

Geographical Distribution of Antimicrobial Exposure Among Very Preterm and Very Low Birth Weight Infants: A Nationwide Database Study in Japan

Overview
Journal PLoS One
Date 2024 Jan 25
PMID 38271353
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To examine spatial effects in neonatal care, we conducted a retrospective cohort study to investigate the geographical distribution of antimicrobial exposure among very preterm and very low birth weight infants in Japan.

Study Design: We utilized a nationwide claims database in Japan to extract prescriptions of injectable antimicrobials for 41,423 very preterm and very low birth weight infants admitted within the first two days of life from April 2010 to March 2021. We identified frequently prescribed antimicrobials, revealed early neonatal exposure and neonatal exposure to each antimicrobial agent by 47 prefectures in Japan, and evaluated their spatial autocorrelation using global and local Moran's I statistics. We then scrutinized regional disparities in antimicrobial drug prescriptions.

Results: The top 10 antimicrobials prescribed to very preterm and very low birth weight infants in Japan were ampicillin, amikacin, gentamicin, cefotaxime, fluconazole, ampicillin combination, micafungin, cefmetazole, cefazolin, and vancomycin. We identified northern cold spots for fluconazole exposure and southern hot spots for ampicillin, amikacin, gentamicin, and cefmetazole exposure. Geographical heterogeneity in the selection of antibacterial and antimycotic agents was observed.

Conclusion: Our study revealed the geographical distribution of antimicrobial exposure among very preterm and very low birth weight infants in Japan, thus disclosing its spatial effects. Further research addressing the spatial effects of neonatal care is needed to understand how drug exposure affects the outcomes of preterm infants.

References
1.
Murphy H, Thomas B, Van Wyk B, Tierney S, Selewski D, Jetton J . Nephrotoxic medications and acute kidney injury risk factors in the neonatal intensive care unit: clinical challenges for neonatologists and nephrologists. Pediatr Nephrol. 2019; 35(11):2077-2088. DOI: 10.1007/s00467-019-04350-3. View

2.
Stoll B, Hansen N, Fanaroff A, Wright L, Carlo W, Ehrenkranz R . Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002; 347(4):240-7. DOI: 10.1056/NEJMoa012657. View

3.
Hirakawa E, Ibara S, Yoshihara H, Kamitomo M, Kodaira Y, Kibe M . Safety, speed, and effectiveness of air transportation for neonates. Pediatr Int. 2020; 63(4):415-422. DOI: 10.1111/ped.14401. View

4.
Clark R, Bloom B, Spitzer A, Gerstmann D . Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics. 2006; 117(1):67-74. DOI: 10.1542/peds.2005-0179. View

5.
Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong K . Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health. 2021; 6(2):106-115. PMC: 8786667. DOI: 10.1016/S2352-4642(21)00311-4. View